In Autumn 2020, DOAJ will be relaunching with a new website with updated functionality, improved search, and a simplified application form. More information is available on our blog. Our API is also changing.

Hide this message

Generation of induced pluripotent stem cells (iPSCs) from human foreskin fibroblasts

Stem Cell Research. 2018;33:79-82

 

Journal Homepage

Journal Title: Stem Cell Research

ISSN: 1873-5061 (Print); 1876-7753 (Online)

Publisher: Elsevier

LCC Subject Category: Science: Biology (General)

Country of publisher: Netherlands

Language of fulltext: English

Full-text formats available: PDF, HTML, ePUB

 

AUTHORS


Friedrich Erdlenbruch (Institute for Virology and Cell Biology, University of Lübeck, Germany)

Jürgen Rohwedel (Corresponding author.; Institute for Virology and Cell Biology, University of Lübeck, Germany)

Philipp Ralfs (Institute for Virology and Cell Biology, University of Lübeck, Germany)

Antonia Thomitzek (Institute for Virology and Cell Biology, University of Lübeck, Germany)

Jan Kramer (Institute for Virology and Cell Biology, University of Lübeck, Germany)

Figen Cakiroglu (Institute for Virology and Cell Biology, University of Lübeck, Germany)

EDITORIAL INFORMATION

Peer review

Editorial Board

Instructions for authors

Time From Submission to Publication: 23 weeks

 

Abstract | Full Text

The human iPS cell line VUZUZLi001-A (hVH-1) was generated from human foreskin fibroblasts to be used as a control line. Reprogramming was performed by retroviral transduction of reprogramming factors OCT4, SOX2, KLF4 and c-MYC.Resource tableUnlabelled TableUnique stem cell line identifierVUZUZLi001-AAlternative name(s) of stem cell linehVH-1InstitutionInstitute of Virology and Cell Biology, University of LübeckContact information of distributorJürgen Rohwedel, [email protected] of cell lineiPSCOriginhumanAdditional origin infoAge: unknownSex: maleEthnicity if known: —Cell sourceforeskin fibroblastsClonalitymixedMethod of reprogrammingretroviral integrationGenetic modificationNOType of modificationN/AAssociated diseaseN/AGene/locusN/AMethod of modificationN/AName of transgene or resistanceN/AInducible/constitutive systemN/ADate archived/stock date2017-08-05Cell line repository/bankN/AEthical approvalEthics Committee University of Lübeck; reference number: 14-100